Your Client Rank:
Loading...
99
Updated 11-Apr-2021
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Astra | 10.6% | 0.2% | -6.0% | -3.6% | 9.4% | 0.1% | 18.2% | 18.3% |
| Vertex | 9.4% | 0.2% | -0.5% | -4.8% | 3.7% | 9.9% | 11.4% | 10.7% |
| Daiichi | 8.9% | 2.5% | 0.1% | -6.1% | 27.0% | -0.5% | 35.3% | 35.1% |
| Lilly | 8.3% | 0.4% | -4.7% | -3.5% | 6.1% | 1.1% | 11.1% | 11.8% |
| Viatris | 7.9% | 2.1% | -0.5% | 0.2% | 6.0% | -1.8% | 16.4% | 1.6% |
| Regeneron | 7.3% | -0.3% | -0.1% | -3.8% | -2.0% | 9.6% | 6.4% | 6.5% |
| Novo | 6.8% | -0.1% | -0.9% | 0.8% | 0.4% | 0.2% | 7.3% | 8.9% |
| Pfizer | 5.7% | 0.3% | -3.9% | -2.9% | 4.6% | 2.1% | 9.8% | 10.2% |
| Merck | 5.4% | 1.2% | -1.9% | -1.5% | 3.9% | 1.5% | 8.0% | 9.1% |
| Alexion | 5.4% | -0.1% | 0.0% | 2.4% | -1.2% | -0.7% | 4.3% | 5.5% |
| Shionogi | 5.0% | 0.0% | 3.8% | -1.7% | -2.2% | -1.7% | 3.4% | 5.8% |
| Eisai | 5.0% | 1.2% | -1.3% | -3.7% | 13.3% | 0.3% | 19.0% | 18.9% |
| AbbVie | 4.8% | -0.4% | -0.6% | -0.7% | 0.1% | 4.1% | 5.0% | 4.5% |
| Roche | 4.7% | 0.3% | -1.4% | -1.1% | 1.7% | 1.7% | 6.6% | 6.9% |
| Lundbeck | 4.6% | 1.3% | -2.7% | -5.8% | 20.1% | 6.5% | 6.2% | 6.3% |
| JnJ | 4.4% | 0.3% | -1.9% | -1.5% | 2.7% | 1.9% | 6.8% | 7.5% |
| Chugai | 3.9% | 1.6% | -1.5% | 0.8% | 2.4% | -1.8% | 7.1% | 7.1% |
| Bristol | 3.9% | -0.8% | -4.2% | -2.2% | 1.2% | 1.5% | 5.1% | 6.2% |
| Astellas | 3.8% | -0.1% | -0.3% | -2.1% | 0.5% | 2.3% | 5.0% | 13.1% |
| Glaxo | 3.8% | 0.3% | -2.2% | 1.3% | 1.9% | 3.6% | 5.1% | 4.8% |
| Novartis | 3.6% | 0.3% | -0.9% | -0.8% | 1.5% | 0.8% | 5.9% | 6.8% |
| Sanofi | 3.5% | 0.7% | -3.2% | -1.8% | 5.6% | -0.6% | 7.9% | 8.0% |
| Amgen | 2.6% | -0.4% | -2.3% | 0.6% | 0.1% | 0.2% | 3.5% | 5.4% |
| Takeda | 0.9% | 1.1% | -2.5% | -1.6% | 10.3% | -11.5% | 20.9% | 21.0% |
| Gilead | 0.8% | 0.0% | -0.7% | -0.4% | 0.9% | 2.5% | 1.5% | 2.3% |
| Teva | 0.6% | 0.8% | -0.1% | 0.4% | 2.0% | 1.0% | 4.7% | 4.3% |
| Bayer | 0.5% | 3.5% | -1.9% | -4.0% | | 18.0% | 1.5% | 1.2% |
| Biogen | -1.8% | -0.4% | 1.8% | 4.1% | -4.4% | -0.4% | -7.6% | -4.4% |
| EU Major | 4.3% | 0.9% | -2.4% | -1.3% | 5.3% | -1.7% | 7.1% | 7.6% |
| Other EU | 4.6% | 1.3% | -2.7% | -5.8% | 20.1% | 6.5% | 6.2% | 6.3% |
| US Major | 5.1% | 0.2% | -2.5% | -1.9% | 2.6% | 2.1% | 7.2% | 7.9% |
| US Big Biotech | 2.8% | -0.1% | -1.0% | 0.0% | -0.3% | 2.1% | 2.7% | 3.6% |
| Other US | 3.9% | 1.5% | -0.3% | -0.1% | 4.3% | -0.4% | 10.7% | 2.7% |
| Japanese | 3.5% | 1.1% | -0.8% | -2.2% | 7.3% | -4.6% | 14.0% | 13.5% |
